Back to Browse Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 1

Adipose inflammation: cause or consequence of obesity-related insulin resistance

Authors Ping Jiao, Haiyan Xu

Published 23 October 2008 Volume 2008:1 Pages 25—31

DOI http://dx.doi.org/10.2147/DMSO.S4180

Review by Single-blind

Peer reviewer comments 3

Ping Jiao, Haiyan Xu

Hallett Center for Diabetes and Endocrinology, Brown Medical School, Providence, RI, USA

Abstract: Obesity constitutes a critical risk factor for the development of many life threatening diseases, particularly insulin resistance and type 2 diabetes. Adipose tissue plays an important role in regulating whole body energy homeostatsis and obesity-related insulin resistance. Inflammation has been commonly linked to insulin resistance. Recent studies demonstrated that adipose tissue is an important source for producing inflammatory molecules in the obese state, primarily due to accumulation of macrophages. Animal models deficient in key inflammatory molecules or with reduced adipose macrophage infiltration are protected from development of obesity-related insulin resistance. Repression of adipose inflammation may be a useful approach to ameliorate obesity-associated metabolic disorders.

Keywords: adipose inflammation, insulin resistance, obesity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Significant increment in the prevalence of overweight and obesity documented between 1994 and 2008 in Mexican college students

H García-Alcala, D Cuevas-Ramos, Ch Genestier-Tamborero, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:79-85

Published Date: 19 April 2010

Alogliptin: a new addition to the class of DPP-4 inhibitors

Radha Andukuri, Andjela Drincic, Marc Rendell

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:117-126

Published Date: 21 July 2009

p38 MAPK inhibition reduces diabetes-induced impairment of wound healing

Satyanarayana Medicherla, Scott Wadsworth, Breda Cullen, Derek Silcock, et al.

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:91-100

Published Date: 23 June 2009

Management of gestational diabetes mellitus

Annunziata Lapolla, Maria Grazia Dalfrà, Domenico Fedele

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2009, 2:73-82

Published Date: 17 June 2009

Comorbidity and glycemia control among patients with type 2 diabetes in primary care

Catherine Hudon, Martin Fortin, Marie-France Dubois, José Almirall

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:33-37

Published Date: 18 November 2008

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes

Bradley Curtis, Risa P Hayes, Sheri Fehnel, Laurie Zografos

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:13-23

Published Date: 14 October 2008

The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes

Juan Churruca, Luis Vigil, Esther Luna, Julian Ruiz-Galiana, Manuel Varela

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:3-11

Published Date: 11 August 2008

Insulin autoimmune syndrome in a patient with ANCA-associated glomerulonephritis

Tsuneyoshi Ka, Yuji Moriwaki, Takeshi Nakanishi, Tetsuya Yamamoto

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2008, 1:1-2

Published Date: 19 June 2008